Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Neoplasms × Lidocaine × Clear all

Phase

Status

Sponsor Class

OTHER 10 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Wounds and Injuries 1 Operable Breast Cancer 1 Neoplasms 1 Head and Neck Neoplasms 1 Cancer Pain 1 Breast Neoplasms 1

Interventions

Drug Therapy 4 pembrolizumab 3 Thermography 2 Surveys and Questionnaires 2 Quality of Life 2 Preoperative Exercise 2 Nivolumab 2 Moxibustion 2 Hematologic Tests 2 Cyclophosphamide 2 Chemoradiotherapy 2 sinovac COVID-19 vaccine 1 lenvatinib 1 ibrutinib 1 fludarabine 1 encorafenib 1 durvalumab 1 binimetinib 1 beta Carotene 1 avelumab 1 atezolizumab 1 Zoledronic Acid 1 Zinc 1 Vitamin E 1 Vascular Access Devices 1 Validation Studies as Topic 1 Urination 1 Ultraviolet Therapy 1 Ultrasonography 1 Trastuzumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04741880 2021-07-30

ELSA

Instituto Nacional de Cancer, Brazil

Phase 2/3 Unknown

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡